<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36106874</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>19</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Enterovirus 3C Protease Cleaves TRIM7 To Dampen Its Antiviral Activity.</ArticleTitle><Pagination><StartPage>e0133222</StartPage><MedlinePgn>e0133222</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e01332-22</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.01332-22</ELocationID><Abstract><AbstractText>Mammalian TRIM7 is an antiviral protein that inhibits multiple human enteroviruses by degrading the viral 2BC protein. Whether TRIM7 is reciprocally targeted by enteroviruses is not known. Here, we report that the 3C protease (3Cpro) from two enteroviruses, coxsackievirus B3 (CVB3) and poliovirus, targets TRIM7 for cleavage. CVB3 3Cpro cleaves TRIM7 at glutamine 24 (Q24), resulting in a truncated TRIM7 that fails to inhibit CVB3 due to dampened E3 ubiquitin ligase activity. TRIM7 Q24 is highly conserved across mammals, except in marsupials, which instead have a naturally occurring histidine (H24) that is not subject to 3Cpro cleavage. Marsupials also express two isoforms of TRIM7, and the two proteins from koalas have distinct antiviral activities. The longer isoform contains an additional exon due to alternate splice site usage. This additional exon contains a unique 3Cpro cleavage site, suggesting that certain enteroviruses may have evolved to target marsupial TRIM7 even if the canonical Q24 is missing. Combined with computational analyses indicating that TRIM7 is rapidly evolving, our data raise the possibility that TRIM7 may be targeted by enterovirus evasion strategies and that evolution of TRIM7 across mammals may have conferred unique antiviral properties. <b>IMPORTANCE</b> Enteroviruses are significant human pathogens that cause viral myocarditis, pancreatitis, and meningitis. Knowing how the host controls these viruses and how the viruses may evade host restriction is important for understanding fundamental concepts in antiviral immunity and for informing potential therapeutic interventions. In this study, we demonstrate that coxsackievirus B3 uses its virally encoded protease to target the host antiviral protein TRIM7 for cleavage, suggesting a potential mechanism of viral immune evasion. We additionally show that TRIM7 has evolved in certain mammalian lineages to express protein variants with distinct antiviral activities and susceptibilities to viral protease-mediated cleavage.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Wenchun</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-0554-1362</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, UT Southwestern Medical Center, Dallas, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDougal</LastName><ForeName>Matthew B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Microbiology, UT Southwestern Medical Center, Dallas, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schoggins</LastName><ForeName>John W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Microbiology, UT Southwestern Medical Center, Dallas, Texas, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP1 AI158124</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI169451</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI169451</GrantID><Agency>Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID)</Agency><Country /></Grant><Grant><GrantID>AI158124</GrantID><Agency>Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000070584">Tripartite Motif Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0RH81L854J</RegistryNumber><NameOfSubstance UI="D005973">Glutamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QD397987E</RegistryNumber><NameOfSubstance UI="D006639">Histidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="Y">3C Viral Proteases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005973" MajorTopicYN="N">Glutamine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006639" MajorTopicYN="N">Histidine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048368" MajorTopicYN="N">Phascolarctidae</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000070584" MajorTopicYN="Y">Tripartite Motif Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="Y">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3C protease</Keyword><Keyword MajorTopicYN="N">TRIM7</Keyword><Keyword MajorTopicYN="N">coxsackievirus B3</Keyword><Keyword MajorTopicYN="N">mammals</Keyword><Keyword MajorTopicYN="N">marsupials</Keyword><Keyword MajorTopicYN="N">virus-host interaction</Keyword><Keyword MajorTopicYN="N">virus-host interactions</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>15</Day><Hour>9</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36106874</ArticleId><ArticleId IdType="pmc">PMC9555159</ArticleId><ArticleId IdType="doi">10.1128/jvi.01332-22</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhou C, Zhang Z, Zhu X, Qian G, Zhou Y, Sun Y, Yu W, Wang J, Lu H, Lin F, Shen Z, Zheng S. 2020. N6-methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1. EBioMedicine 59:102955. 10.1016/j.ebiom.2020.102955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102955</ArticleId><ArticleId IdType="pmc">PMC7452680</ArticleId><ArticleId IdType="pubmed">32853985</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Zhang G, Qin X, Huang Y, Ren X, Sun J, Ma S, Liu Y, Song D, Liu Y, Cui Y, Wang H, Wang J. 2021. Negative regulation of RNF90 on RNA virus-triggered antiviral immune responses targeting MAVS. Front Immunol 12:730483. 10.3389/fimmu.2021.730483.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.730483</ArticleId><ArticleId IdType="pmc">PMC8429505</ArticleId><ArticleId IdType="pubmed">34512666</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J, Lu Z, Wang X, Liu Y, Han T, Wang Y, Wang T, Gan M, Xie C, Wang J, Yu B. 2020. E3 ubiquitin ligase TRIM7 negatively regulates NF-kappa B signaling pathway by degrading p65 in lung cancer. Cell Signal 69:109543. 10.1016/j.cellsig.2020.109543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2020.109543</ArticleId><ArticleId IdType="pubmed">31958511</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Liu Y, Cui Y, Song D, Zhang G, Ma S, Liu Y, Chen M, Chen F, Wang H, Wang J. 2020. RNF90 negatively regulates cellular antiviral responses by targeting MITA for degradation. PLoS Pathog 16:e1008387. 10.1371/journal.ppat.1008387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008387</ArticleId><ArticleId IdType="pmc">PMC7069649</ArticleId><ArticleId IdType="pubmed">32126128</ArticleId></ArticleIdList></Reference><Reference><Citation>Giraldo MI, Xia H, Aguilera-Aguirre L, Hage A, van Tol S, Shan C, Xie X, Sturdevant GL, Robertson SJ, McNally KL, Meade-White K, Azar SR, Rossi SL, Maury W, Woodson M, Ramage H, Johnson JR, Krogan NJ, Morais MC, Best SM, Shi P-Y, Rajsbaum R. 2020. Envelope protein ubiquitination drives entry and pathogenesis of Zika virus. Nature 585:414–419. 10.1038/s41586-020-2457-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2457-8</ArticleId><ArticleId IdType="pmc">PMC7501154</ArticleId><ArticleId IdType="pubmed">32641828</ArticleId></ArticleIdList></Reference><Reference><Citation>Orchard RC, Sullender ME, Dunlap BF, Balce DR, Doench JG, Virgin HW. 2018. Identification of antinorovirus genes in human cells using genome-wide CRISPR activation screening. J Virol 93:e01324-18. 10.1128/JVI.01324-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01324-18</ArticleId><ArticleId IdType="pmc">PMC6288323</ArticleId><ArticleId IdType="pubmed">30305350</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan W, Mar KB, Sari L, Gaszek IK, Cheng Q, Evers BM, Shelton JM, Wight-Carter M, Siegwart DJ, Lin MM, Schoggins JW. 2021. TRIM7 inhibits enterovirus replication and promotes emergence of a viral variant with increased pathogenicity. Cell 184:3410–3425.e17. 10.1016/j.cell.2021.04.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.04.047</ArticleId><ArticleId IdType="pmc">PMC8276836</ArticleId><ArticleId IdType="pubmed">34062120</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowles N, Richardson P, Olsen E, Archard L. 1986. Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet i:1120–1123. 10.1016/s0140-6736(86)91837-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(86)91837-4</ArticleId><ArticleId IdType="pubmed">2871380</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy S, Chapman N, McManus B, Pallansch M, Beck M, Carstens J. 1990. A molecular and serologic evaluation of enteroviral human myocarditis involvement in human myocarditis. J Mol Cell Cardiol 22:403–414. 10.1016/0022-2828(90)91476-N.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-2828(90)91476-N</ArticleId><ArticleId IdType="pubmed">2167382</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin O, Sole MJ, Butany JW, Chia WK, McLaughlin PR, Liu P, Liew CC. 1990. Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 82:8–16. 10.1161/01.cir.82.1.8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.82.1.8</ArticleId><ArticleId IdType="pubmed">2163780</ArticleId></ArticleIdList></Reference><Reference><Citation>Vourinen T, Kallajoki M, Hyypia T, Vainionpaa R. 1989. Coxsackievirus B3-induced acute pancreatitis: analysis of histopathological and viral parameters in a mouse model. Br J Exp Pathol 70:395–403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2040566</ArticleId><ArticleId IdType="pubmed">2548562</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy S, Höfling K, Pirruccello S, Lane PH, Reyna SM, Gauntt CJ. 2000. Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice. J Med Virol 62:70–81. 10.1002/1096-9071(200009)62:1&lt;70::AID-JMV11&gt;3.0.CO;2-R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-9071(200009)62:1&lt;70::AID-JMV11&gt;3.0.CO;2-R</ArticleId><ArticleId IdType="pubmed">10935991</ArticleId></ArticleIdList></Reference><Reference><Citation>Chehadeh W, Kerr-Conte J, Pattou F, Alm G, Lefebvre J, Wattré P, Hober D. 2000. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in β cells. J Virol 74:10153–10164. 10.1128/jvi.74.21.10153-10164.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.21.10153-10164.2000</ArticleId><ArticleId IdType="pmc">PMC102054</ArticleId><ArticleId IdType="pubmed">11024144</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Spence-Davizon E, Osborne C, Press C, Schreiner TL, Martin J, Messer R, Maloney J, Burakoff A, Barnes M, Rogers S, Lopez AS, Routh J, Gerber SI, Oberste MS, Nix WA, Abzug MJ, Tyler KL, Herlihy R, Dominguez SR. 2020. Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort study. Lancet Infect Dis 20:230–239. 10.1016/S1473-3099(19)30632-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(19)30632-2</ArticleId><ArticleId IdType="pmc">PMC11284833</ArticleId><ArticleId IdType="pubmed">31859216</ArticleId></ArticleIdList></Reference><Reference><Citation>Chau DHW, Yuan J, Zhang H, Cheung P, Lim T, Liu Z, Sall A, Yang D. 2007. Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1. Apoptosis 12:513–524. 10.1007/s10495-006-0013-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-006-0013-0</ArticleId><ArticleId IdType="pubmed">17195095</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson PJ, Ye X, Qiu Y, Zhang HM, Hemida MG, Wang F, Lim T, Gu A, Cho B, Kim H, Fung G, Granville DJ, Yang D. 2016. Cleavage of DAP5 by coxsackievirus B3 2A protease facilitates viral replication and enhances apoptosis by altering translation of IRES-containing genes. Cell Death Differ 23:828–840. 10.1038/cdd.2015.145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2015.145</ArticleId><ArticleId IdType="pmc">PMC4832101</ArticleId><ArticleId IdType="pubmed">26586572</ArticleId></ArticleIdList></Reference><Reference><Citation>de Breyne S, Bonderoff JM, Chumakov KM, Lloyd RE, Hellen CUT. 2008. Cleavage of eukaryotic initiation factor eIF5B by enterovirus 3C proteases. Virology 378:118–122. 10.1016/j.virol.2008.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2008.05.019</ArticleId><ArticleId IdType="pmc">PMC2580754</ArticleId><ArticleId IdType="pubmed">18572216</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamphear BJ, Kirchweger R, Skern T, Rhoads RE. 1995. Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. J Biol Chem 270:21975–21983. 10.1074/jbc.270.37.21975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.37.21975</ArticleId><ArticleId IdType="pubmed">7665619</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel MR, Loo Y, Horner SM, Gale M, Jr, Malik HS. 2012. Convergent evolution of escape from hepaciviral antagonism in primates. PLoS Biol 10:e1001282. 10.1371/journal.pbio.1001282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1001282</ArticleId><ArticleId IdType="pmc">PMC3302847</ArticleId><ArticleId IdType="pubmed">22427742</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Xiao X, Xue Q, Jin Q, He B, Wang J. 2013. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J Virol 87:1690–1698. 10.1128/JVI.01855-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01855-12</ArticleId><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Xi X, Lei X, Zhang X, Cui S, Wang J, Jin Q, Zhao Z. 2013. Enterovirus 71 protease 2A pro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog 9:e1003231. 10.1371/journal.ppat.1003231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003231</ArticleId><ArticleId IdType="pmc">PMC3605153</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Z, Li L, Lei X, Zhou H, Zhou Z, He B, Wang J. 2014. Enterovirus 68 3C protease cleaves TRIF to attenuate antiviral responses mediated by Toll-like receptor 3. J Virol 88:6650–6659. 10.1128/JVI.03138-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03138-13</ArticleId><ArticleId IdType="pmc">PMC4054379</ArticleId><ArticleId IdType="pubmed">24672048</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Z, Liu L, Lei X, Zhou Z, He B, Wang J. 2016. 3C protease of enterovirus D68 inhibits cellular defense mediated by interferon regulatory factor 7. J Virol 90:1613–1621. 10.1128/JVI.02395-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02395-15</ArticleId><ArticleId IdType="pmc">PMC4719596</ArticleId><ArticleId IdType="pubmed">26608321</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Langereis MA, Lork M, Nguyen M, Hato SV, Lanke K, Emdad L, Bhoopathi P, Fisher PB, Lloyd RE, van Kuppeveld FJM. 2014. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J Virol 88:3369–3378. 10.1128/JVI.02712-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02712-13</ArticleId><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee A, Morosky SA, Delorme-Axford E, Dybdahl-Sissoko N, Oberste MS, Wang T, Coyne CB. 2011. The coxsackievirus B 3C pro protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog 7:e1001311. 10.1371/journal.ppat.1001311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001311</ArticleId><ArticleId IdType="pmc">PMC3059221</ArticleId><ArticleId IdType="pubmed">21436888</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Q, Gaska JM, Douam F, Wei L, Kim D, Balev M, Heller B, Ploss A. 2018. Species-specific disruption of STING-dependent antiviral cellular defenses by the Zika virus NS2B3 protease. Proc Natl Acad Sci USA 115:E6310–E6318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6142274</ArticleId><ArticleId IdType="pubmed">29915078</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguirre S, Maestre AM, Pagni S, Patel JR, Savage T, Gutman D, Maringer K, Bernal-Rubio D, Shabman RS, Simon V, Rodriguez-Madoz JR, Mulder LCF, Barber GN, Fernandez-Sesma A. 2012. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog 8:e1002934. 10.1371/journal.ppat.1002934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002934</ArticleId><ArticleId IdType="pmc">PMC3464218</ArticleId><ArticleId IdType="pubmed">23055924</ArticleId></ArticleIdList></Reference><Reference><Citation>Moustaqil M, Ollivier E, Chiu H-P, Van Tol S, Rudolffi-Soto P, Stevens C, Bhumkar A, Hunter DJB, Freiberg AN, Jacques D, Lee B, Sierecki E, Gambin Y. 2021. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species. Emerg Microbes Infect 10:178–195. 10.1080/22221751.2020.1870414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1870414</ArticleId><ArticleId IdType="pmc">PMC7850364</ArticleId><ArticleId IdType="pubmed">33372854</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, Chen J, Tian L, Zhou Y, Xu S, Long S, Wang D, Fang L, Xiao S. 2020. Porcine deltacoronavirus nsp5 cleaves DCP1A to decrease its antiviral activity. J Virol 94:e02162-19. 10.1128/JVI.02162-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02162-19</ArticleId><ArticleId IdType="pmc">PMC7375372</ArticleId><ArticleId IdType="pubmed">32461317</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Wang J, Cheng G. 2021. Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1. Proc Natl Acad Sci USA 118:e2107108118. 10.1073/pnas.2107108118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2107108118</ArticleId><ArticleId IdType="pmc">PMC8449311</ArticleId><ArticleId IdType="pubmed">34452991</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y, Lau KS, Kuo R, Horng J. 2017. dsRNA binding domain of PKR is proteolytically released by enterovirus A71 to facilitate viral replication. Front Cell Infect Microbiol 7:284. 10.3389/fcimb.2017.00284.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2017.00284</ArticleId><ArticleId IdType="pmc">PMC5487429</ArticleId><ArticleId IdType="pubmed">28702377</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris KS, Reddigari SR, Nicklin MJH, Hammerle T, Wimmer E. 1992. Purification and characterization of poliovirus polypeptide 3CD, a proteinase and a precursor for RNA polymerase. J Virol 66:7481–7489. 10.1128/JVI.66.12.7481-7489.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.66.12.7481-7489.1992</ArticleId><ArticleId IdType="pmc">PMC240456</ArticleId><ArticleId IdType="pubmed">1331532</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagdeo JM, Dufour A, Klein T, Solis N, Kleifeld O, Kizhakkedathu J, Luo H, Overall CM, Jan E. 2018. N-terminomics TAILS identifies host cell substrates of poliovirus and coxsackievirus B3 3C proteinases that modulate virus infection. J Virol 92:e02211-17. 10.1128/JVI.02211-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02211-17</ArticleId><ArticleId IdType="pmc">PMC5874412</ArticleId><ArticleId IdType="pubmed">29437971</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. 2011. A diverse range of gene products are effectors of the type i interferon antiviral response. Nature 472:481–485. 10.1038/nature09907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09907</ArticleId><ArticleId IdType="pmc">PMC3409588</ArticleId><ArticleId IdType="pubmed">21478870</ArticleId></ArticleIdList></Reference><Reference><Citation>Koliopoulos MG, Esposito D, Christodoulou E, Taylor IA, Rittinger K. 2016. Functional role of TRIM E 3 ligase oligomerization and regulation of catalytic activity. EMBO J 35:1204–1218. 10.15252/embj.201593741.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201593741</ArticleId><ArticleId IdType="pmc">PMC4864278</ArticleId><ArticleId IdType="pubmed">27154206</ArticleId></ArticleIdList></Reference><Reference><Citation>Anandapadamanaban M, Kyriakidis NC, Csizmók V, Wallenhammar A, Espinosa AC, Ahlner A, Round AR, Trewhella J, Moche M, Wahren-Herlenius M, Sunnerhagen M. 2019. E3 ubiquitin-protein ligase TRIM21-mediated lysine capture by UBE2E1 reveals substrate-targeting mode of a ubiquitin-conjugating E2. J Biol Chem 294:11404–11419. 10.1074/jbc.RA119.008485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA119.008485</ArticleId><ArticleId IdType="pmc">PMC6663867</ArticleId><ArticleId IdType="pubmed">31160341</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens RV, Esposito D, Rittinger K. 2019. Characterisation of class VI TRIM RING domains: linking RING activity to C-terminal domain identity. Life Sci Alliance 2:e201900295. 10.26508/lsa.201900295.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.201900295</ArticleId><ArticleId IdType="pmc">PMC6487577</ArticleId><ArticleId IdType="pubmed">31028095</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamauchi K, Wada K, Tanji K, Tanaka M, Kamitani T. 2008. Ubiquitination of E3 ubiquitin ligase TRIM5α and its potential role. FEBS J 275:1540–1555. 10.1111/j.1742-4658.2008.06313.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2008.06313.x</ArticleId><ArticleId IdType="pubmed">18312418</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimuro M, Sawada H, Yokosawa H. 1994. Production and characterization of monoclonal antibodies specific to multi-ubiquitin chains of polyubiquitinated proteins. FEBS Lett 349:173–180. 10.1016/0014-5793(94)00647-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(94)00647-4</ArticleId><ArticleId IdType="pubmed">7519568</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockhurst MA, Chapman T, King KC, Mank JE, Paterson S, Hurst GDD. 2014. Running with the Red Queen: the role of biotic conflicts in evolution. Proc Biol Sci 281:20141382. 10.1098/rspb.2014.1382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rspb.2014.1382</ArticleId><ArticleId IdType="pmc">PMC4240979</ArticleId><ArticleId IdType="pubmed">25355473</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith MD, Wertheim JO, Weaver S, Murrell B, Scheffler K, Pond SLK. 2015. Less is more: an adaptive branch-site random effects model for efficient detection of episodic diversifying selection. Mol Biol Evol 32:1342–1353. 10.1093/molbev/msv022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msv022</ArticleId><ArticleId IdType="pmc">PMC4408413</ArticleId><ArticleId IdType="pubmed">25697341</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed M, Kapell S, Hertz NT, Wu X, Bell K, Ashbrook AW, Mark MT, Zebroski HA, Neal ML, Flodström-Tullberg M, MacDonald MR, Aitchison JD, Molina H, Rice CM. 2020. Defining the proteolytic landscape during enterovirus infection. PLoS Pathog 16:e1008972. 10.1371/journal.ppat.1008927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008927</ArticleId><ArticleId IdType="pmc">PMC7549765</ArticleId><ArticleId IdType="pubmed">32997711</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobbs M, Pavasovic A, King AG, Prentis PJ, Eldridge MDB, Chen Z, Colgan DJ, Polkinghorne A, Wilkins MR, Flanagan C, Gillett A, Hanger J, Johnson RN, Timms P. 2014. A transcriptome resource for the koala (Phascolarctos cinereus): insights into koala retrovirus transcription and sequence diversity. BMC Genomics 15:786–716. 10.1186/1471-2164-15-786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-15-786</ArticleId><ArticleId IdType="pmc">PMC4247155</ArticleId><ArticleId IdType="pubmed">25214207</ArticleId></ArticleIdList></Reference><Reference><Citation>Sironi M, Cagliani R, Forni D, Clerici M. 2015. Evolutionary insights into host-pathogen interactions from mammalian sequence data. Nat Rev Genet 16:224–236. 10.1038/nrg3905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3905</ArticleId><ArticleId IdType="pmc">PMC7096838</ArticleId><ArticleId IdType="pubmed">25783448</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty MD, Malik HS. 2012. Rules of engagement: molecular insights from host-virus arms races. Annu Rev Genet 46:677–700. 10.1146/annurev-genet-110711-155522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genet-110711-155522</ArticleId><ArticleId IdType="pubmed">23145935</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenthorey JL, Emerman M, Malik HS. 2022. Evolutionary landscapes of host-virus arms races. Annu Rev Immunol 40:271–294. 10.1146/annurev-immunol-072621-084422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-072621-084422</ArticleId><ArticleId IdType="pubmed">35080919</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreiro LB, Quintana-Murci L. 2010. From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat Rev Genet 11:17–30. 10.1038/nrg2698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2698</ArticleId><ArticleId IdType="pubmed">19953080</ArticleId></ArticleIdList></Reference><Reference><Citation>Duggal NK, Emerman M. 2012. Evolutionary conflicts between viruses and restriction factors shape immunity. Nat Rev Immunol 12:687–695. 10.1038/nri3295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3295</ArticleId><ArticleId IdType="pmc">PMC3690816</ArticleId><ArticleId IdType="pubmed">22976433</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z. 2007. PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol 24:1586–1591. 10.1093/molbev/msm088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msm088</ArticleId><ArticleId IdType="pubmed">17483113</ArticleId></ArticleIdList></Reference><Reference><Citation>Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Pond SLK. 2012. Detecting individual sites subject to episodic diversifying selection. PLoS Genet 8:e1002764. 10.1371/journal.pgen.1002764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002764</ArticleId><ArticleId IdType="pmc">PMC3395634</ArticleId><ArticleId IdType="pubmed">22807683</ArticleId></ArticleIdList></Reference><Reference><Citation>Murrell B, Moola S, Mabona A, Weighill T, Sheward D, Kosakovsky Pond SL, Scheffler K. 2013. FUBAR: a fast, unconstrained Bayesian approximation for inferring selection. Mol Biol Evol 30:1196–1205. 10.1093/molbev/mst030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/mst030</ArticleId><ArticleId IdType="pmc">PMC3670733</ArticleId><ArticleId IdType="pubmed">23420840</ArticleId></ArticleIdList></Reference><Reference><Citation>Malfavon-Borja R, Sawyer SL, Wu LI, Emerman M, Malik HS. 2013. An evolutionary screen highlights canonical and noncanonical candidate antiviral genes within the primate TRIM gene family. Genome Biol Evol 5:2141–2154. 10.1093/gbe/evt163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gbe/evt163</ArticleId><ArticleId IdType="pmc">PMC3845644</ArticleId><ArticleId IdType="pubmed">24158625</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo J-S, Suh H-Y, Park S-Y, Oh B-H. 2006. Structural basis for protein recognition by B30.2/SPRY domains. Mol Cell 24:967–976. 10.1016/j.molcel.2006.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2006.11.009</ArticleId><ArticleId IdType="pubmed">17189197</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenthorey JL, Young C, Sodeinde A, Emerman M, Malik HS. 2020. Mutational resilience of antiviral restriction favors primate TRIM5α in host-virus evolutionary arms races. Elife 15:e59988. 10.7554/eLife.59988.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.59988</ArticleId><ArticleId IdType="pmc">PMC7492085</ArticleId><ArticleId IdType="pubmed">32930662</ArticleId></ArticleIdList></Reference><Reference><Citation>Krumbholz A, Egerer R, Braun H, Schmidtke M, Rimek D, Kroh C, Hennig B, Groth M, Sauerbrei A, Zell R. 2016. Analysis of an echovirus 18 outbreak in Thuringia, Germany: insights into the molecular epidemiology and evolution of several enterovirus species B members. Med Microbiol Immunol 205:471–483. 10.1007/s00430-016-0464-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-016-0464-z</ArticleId><ArticleId IdType="pubmed">27369854</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornell CT, Kiosses WB, Harkins S, Whitton JL. 2007. Coxsackievirus B3 proteins directionally complement each other to downregulate surface major histocompatibility complex class I. J Virol 81:6785–6797. 10.1128/JVI.00198-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00198-07</ArticleId><ArticleId IdType="pmc">PMC1933326</ArticleId><ArticleId IdType="pubmed">17442717</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Stecher G, Li M, Knyaz C, Tamura K, MEGA X. 2018. Molecular Evolutionary Genetics Analysis across computing platforms. Mol Biol Evol 35:1547–1549. 10.1093/molbev/msy096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msy096</ArticleId><ArticleId IdType="pmc">PMC5967553</ArticleId><ArticleId IdType="pubmed">29722887</ArticleId></ArticleIdList></Reference><Reference><Citation>Castresana J. 2000. Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis. Mol Biol Evol 17:540–552. 10.1093/oxfordjournals.molbev.a026334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.molbev.a026334</ArticleId><ArticleId IdType="pubmed">10742046</ArticleId></ArticleIdList></Reference><Reference><Citation>Glez-Pena D, Gomez-Blanco D, Reboiro-Jato M, Fdez-Riverola F, Posada D. 2010. ALTER: program-oriented conversion of DNA and protein alignments. Nucleic Acids Res 38:W14–W18. 10.1093/nar/gkq321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkq321</ArticleId><ArticleId IdType="pmc">PMC2896128</ArticleId><ArticleId IdType="pubmed">20439312</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosakovsky Pond SL, Poon AFY, Velazquez R, Weaver S, Hepler NL, Murrell B, Shank SD, Magalis BR, Bouvier D, Nekrutenko A, Wisotsky S, Spielman SJ, Frost SDW, Muse SV. 2020. HyPhy 2. 5—a customizable platform for evolutionary hypothesis testing using phylogenies. Mol Biol Evol 37:295–299. 10.1093/molbev/msz197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msz197</ArticleId><ArticleId IdType="pmc">PMC8204705</ArticleId><ArticleId IdType="pubmed">31504749</ArticleId></ArticleIdList></Reference><Reference><Citation>Weaver S, Shank SD, Spielman SJ, Li M, Muse SV, Pond SLK. 2018. Datamonkey 2. 0: a modern web application for characterizing selective and other evolutionary processes. Mol Biol Evol 35:773–777. 10.1093/molbev/msx335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msx335</ArticleId><ArticleId IdType="pmc">PMC5850112</ArticleId><ArticleId IdType="pubmed">29301006</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Stecher G, Suleski M, Hedges SB. 2017. TimeTree: a resource for timelines, timetrees, and divergence times. Mol Biol Evol 34:1812–1819. 10.1093/molbev/msx116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msx116</ArticleId><ArticleId IdType="pubmed">28387841</ArticleId></ArticleIdList></Reference><Reference><Citation>Crooks GE, Hon G, Chandonia J, Brenner SE. 2004. WebLogo: a sequence logo generator. Genome Res 14:1188–1190. 10.1101/gr.849004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.849004</ArticleId><ArticleId IdType="pmc">PMC419797</ArticleId><ArticleId IdType="pubmed">15173120</ArticleId></ArticleIdList></Reference><Reference><Citation>Källberg M, Wang H, Wang S, Peng J, Wang Z, Lu H, Xu J. 2012. Template-based protein structure modeling using the RaptorX web server. Nat Protoc 7:1511–1522. 10.1038/nprot.2012.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2012.085</ArticleId><ArticleId IdType="pmc">PMC4730388</ArticleId><ArticleId IdType="pubmed">22814390</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>